期刊文献+

吡格列酮和胰岛素治疗2型糖尿病患者的临床效果观察

Clinical effect of pioglitazone and insulin in the treatment of patients with type 2 diabetes
下载PDF
导出
摘要 目的:探讨吡格列酮和胰岛素治疗2型糖尿病的效果。方法:收治2型糖尿病患者112例,随机分为常规组与研究组,各56例。常规组单纯用胰岛素治疗,研究组在此基础之上联合吡格列酮。结果:研究组空腹血糖、餐后2 h血糖水平、糖化血红蛋白以及胰岛素用量显著低于常规组(P<0.05)。结论:吡格列酮联合胰岛素治疗2型糖尿,可获得满意疗效,有利于患者血糖控制,减少每天胰岛素用量,且不良反应少,安全性高。 Objective:To investigate the effect of pioglitazone and insulin in the treatment of type 2 diabetes.Methods:112 patients with type 2 diabetes were randomly divided into the routine group and the study group,with 56 cases in each group.The routine group was treated with insulin alone,and the study group combined with pioglitazone on the basis of insulin.Results:The fasting blood glucose,2h postprandial blood glucose level,glycated hemoglobin and insulin dosage in the study group were significantly lower than that of the conventional group(P<0.05).Conclusion:Pioglitazone combined with insulin in the treatment of type 2 diabetes can achieve satisfactory results,which is conducive to blood glucose control and daily dosage of insulin,and has fewer adverse reactions and high safety.
作者 徐春雷 Xu Chunlei(Sheshan Community Health Service Center in Songjiang District,Shanghai City 201602)
出处 《中国社区医师》 2018年第12期53-54,共2页 Chinese Community Doctors
关键词 吡格列酮 胰岛素 2型糖尿病 Pioglitazone Insulin Type 2 diabetes mellitus
  • 相关文献

二级参考文献54

  • 1李鸿娟,张东辉,刘海津.吡格列酮联合二甲双胍对2型糖尿病患者胰岛素抵抗及脂肪细胞因子水平的影响[J].中国老年学杂志,2014,34(9):2416-2417. 被引量:25
  • 2杨秀真,陈芳,刘志强.吡格列酮与磺酰脲类药物合用治疗2型糖尿病的疗效分析[J].中国综合临床,2004,20(10):899-900. 被引量:3
  • 3杨兆军,颜树峰,邢小燕,王宣,李光伟.盐酸吡格列酮对磺脲类和双胍类药物联合治疗失效的2型糖尿病患者的疗效观察[J].中国综合临床,2005,21(12):1099-1101. 被引量:9
  • 4Chang YH,Chang DM,Lin KC,et al.Visfatin in overweight/obesity,type 2diabetes mellitus,insulin resistance,metabolic syndrome and cardiovascular diseases:a meta-analysis and systemic review[J].Diabetes Metab Res Rev,2011,27(6):515-517.
  • 5Sun WL,Chen LL,Zhang SZ,et al.Inflammatory cytokines,adiponectin,insulin resistance and metabolic controlafter periodontal intervention in patients with type 2diabetes and chronic periodontitis[J].Intern Med,2011,50(15):1569-1574.
  • 6Yang SJ,Hwang SY,Choi HY,et al.Serum selenoprotein P levels in patients with type 2diabetes and prediabetes:implications for insulin resistance,implications and atherosclerosis[J].J Clin Endocrinol Metab,2011,96(8):E325-1329.
  • 7Gads E,Owens AW,Gore MO,et a1.Discordant effects of pioglitazone on novel inflammatory biomarkers[J].Am Heart J,2013,165(4):609-614.
  • 8Satirapoj B,Supasyndh O,Dispan R,et al.Apolipoprotein E genetic polymorphisms and the development of nephropathy in type 2diabetes[J].J Med Assoc Thai,2013,96(9):1119-1126.
  • 9Li X,Zhang N,Li Y,et al.Effects of metformin and pioglitazone on peripheral insulin resistance and beta-cell function in obesity:a double-blind,randomized,controlled study[J].J Int Med Res,2011,39(2):358-365.
  • 10Berg AH, Combs TP, Du X, et al. The alipocyte-secrects protein Acrp 30 enhances hepatic Insulin action[ J]. Nat Med ,2001,7 ( 8 ) :947.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部